<strong>Creativity</strong> and <strong>Innovation</strong><br /> for the patient Development of <strong>new therapies</strong> and <br /><strong>treatments</strong> to improve citizens health <strong>Internationally renowned</strong><br /> biomedical research

Creativity and Innovation
for the patient

Development of new therapies and
treatments to improve citizens health

Internationally renowned
biomedical research

Home

Rafael Peláez Cristóbal

Rafael Peláez Cristóbal

Rafael Peláez Cristóbal

Email: rpelaez@riojasalud.es

Phone: +34 941 278 770 (Ext.:84866)

Biosketch

Dr. Rafael Peláez Cristóbal, got his degree in Biology at University of Oviedo in 2004 and he finished his Ph.D. studies in the Department of Biochemistry and Molecular Biology at the University of Oviedo (Asturias-Spain) in 2009. From 2010 up to 2014 he was working as Post Doctoral researcher in the Department of Oncology at CIMA (Centre for Applied Medical Research) supported by the Torres Quevedo program.

During his Ph.D., Rafael Peláez worked in genetic regulation of metabolism, particularly in the role of Hexokinase 2 (Hxk2) in the glucose repression pathway. He studied several aspects of the structural domains of the Hxk2, and its nucleo-citoplasmic traffic. In his postdoctoral stage in CIMA his main research area was the characterization of the role of integrins in the migration of lung cancer cells. He has also contributed to other projects, such as the characterization of Collapsin response mediator protein-2 (CRMP-2) during cell mitosis of lung cancer cells, and 3D cell migration of cancer cells in microfluidic devices.

From 2014 to 2015 he was working as biotechnology researcher in BIOMASS BOOSTER, SL in projects related to the genetic transformation of plants for the increased production of biomass.

In this moment he is working as Post Doctoral researcher in the Biomarkers and Molecular Signaling group at CIBIR (Center for Biomedical Research of La Rioja), where he participates in projects to develop and optimize nanoparticles with therapeutic activity in cellular and murine models of age-related macular degeneration, retinal injury and cancer.

As result of his work he has published several articles in scientific journals of high impact, as well as communications in national and international congresses. He has received some prizes for the best communication (Roche poster award of the Spanish Society of Biochemistry and Molecular Biology) and the extraordinary P.hD prize of Biochemistry and Molecular Biology in the year 2011. Along these years he has been meritorious to obtain a positive evaluation for Assistant Professor Contracts by the National Agency of Evaluation of Quality and Accreditation (ANECA).

Date

11 April 2017

Categories

Biomarkers and Molecular Signaling

Partners

La Rioja Crece con Europa. Programa Operativo FEDER de La Rioja, 2014-2020

Unesco, Organización de las naciones unidas para la educación la ciencia y la cultura. Centro Nacional de Documentación y Bioética

Diploma de compromiso con la excelencia

Etiqueta de calificación energética

ISO 14001:2015

© 2021 Rioja Salud - C/ Piqueras, 98 – 3ª Planta · 26006 · Logroño · La Rioja · Telf.: 941 278 855 · Fax: 941 278 887